Breaking News Instant updates and real-time market news.

BX

Blackstone

$35.83

-0.16 (-0.44%)

, DB

Deutsche Bank

$8.95

0.085 (0.96%)

10:23
04/17/19
04/17
10:23
04/17/19
10:23

Blackstone exploring sale of Cosmopolitan hotel in Las Vegas, WSJ reports

Blackstone (BX) has retained Deutsche Bank (DB) and PJT Partners (PJT) to explore a potential sale of the Cosmopolitan hotel and casino, The Wall Street Journal's Craig Karmin reports, citing people familiar with the matter. Blackstone acquired the Cosmopolitan in 2014 for $1.7B, and some real estate casino executives say a sale could bring $4B or more if it goes to another casino operator. The hotel and casino is expected to attraction from industry buyers, possibly including MGM Resorts (MGM) and Wynn Resorts (WYNN), and could also draw interest from Asian firms like Genting Group, some industry executives and bankers say. Reference Link

BX

Blackstone

$35.83

-0.16 (-0.44%)

DB

Deutsche Bank

$8.95

0.085 (0.96%)

PJT

PJT Partners

$40.75

-1.05 (-2.51%)

MGM

MGM Resorts

$27.71

0.33 (1.21%)

WYNN

Wynn Resorts

$144.62

-0.1 (-0.07%)

  • 18

    Apr

  • 24

    Apr

  • 26

    Apr

  • 29

    Apr

  • 29

    Apr

  • 01

    May

  • 07

    May

  • 29

    May

  • 11

    Jun

BX Blackstone
$35.83

-0.16 (-0.44%)

01/02/19
SUSQ
01/02/19
UPGRADE
Target $31
SUSQ
Positive
Crocs upgraded to Positive at Susquehanna
As reported previously, Susquehanna analyst Sam Poser upgraded Crocs (CROX) to Positive from Neutral. The analyst cited the recent repurchase and conversion of Blackstone's (BX) preferred stock position as it removes a substantial financial overhang from the company's capital structure and shifts more control of the business into the hands of existing and potential shareholders. In addition, the business continues to accelerate as processes and products improve and the brand gains traction, said Poser, who raised his price target to $31 from $25 on Crocs shares.
11/30/18
MSCO
11/30/18
NO CHANGE
Target $42
MSCO
Overweight
Morgan Stanley more positive on Blackstone growth path after management meeting
After recently hosting an investor meeting with Jon Gray, Blackstone's President and COO, Morgan Stanley analyst Michael Cyprys said he is more positive on the company's growth trajectory, stating that its $130B fundraising pipeline should drive 50% growth in fee-related earnings over the next two years. The analyst, who also thinks a potential C-Corp conversion could unlock value in 2019, keeps an Overweight rating and $42 price target on Blackstone, adding that he thinks the shares could trade near $38 in the near-term if the market begins to assign higher odds to such a C-Corp change.
09/25/18
ARGS
09/25/18
NO CHANGE
Target $46
ARGS
Buy
Blackstone price target raised to $46 from $39 at Argus
Argus analyst Stephen Biggar raised his price target on Blackstone to $46 and kept his Buy rating after its Investor Day presentation on Friday, citing the company's outlined plans to grow its assets under management to $1T from $439B currently. The analyst states that Blackstone is seeing "sees considerable growth in real estate, private equity, infrastructure, tactical opportunities and credit assets", adding that while the $1T target is "aggressive", it is also achievable, requiring "continuing cooperative economic environment and fundraising efforts". Biggar also anticipates Blackstone's "fee-related earnings component to grow significantly over the next two years" as its flagship funds reach key milestones, helping reduce earnings volatility and yielding "more consistent" dividend payouts.
04/15/19
SBSH
04/15/19
UPGRADE
Target $35
SBSH
Neutral
Citi upgrades Franklin Resources, Artisan to Neutral from Sell
Citi analyst William Katz upgraded both Franklin Resources (BEN) and Artisan Partners (APAM) to Neutral from Sell. The analyst raised his price target to $35 from $28 for the former and to $25 from $20 for the latter. Ahead of the Q1 earnings season, however, the analyst favors the Alternatives. His top picks are Och-Ziff Capital (OZM), Brookfield (BAM) and Blackstone (BX). Katz, though, is "tactically less negative" on the Traditional asset managers.
DB Deutsche Bank
$8.95

0.085 (0.96%)

08/13/18
BOFA
08/13/18
DOWNGRADE
Target $9
BOFA
Underperform
Deutsche Bank downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Andrew Stimpson downgraded Deutsche Bank to Underperform from Neutral saying he expects the earnings downgrade cycle to continue given CIB revenue headwinds.
08/10/18
08/10/18
DOWNGRADE

Underweight
Morgan Stanley cuts Deutsche Bank to Underweight on limited top-line visibility
As previously reported, Morgan Stanley analyst Magdalena Stoklosa downgraded Deutsche Bank to Underweight from Equal Weight, stating that while she gives management "full credit" for its cost cutting efforts, it is hard to have any visibility on the top line. She assumes 2018-20 revenue CAGR of just 1.5%, which is below the average for Eurozone banks and below managements target of 4%. While recognizing the risk of downgrading Deutsche Bank "at the bottom," Stoklosa sees current conditions as unlikely to be conducive to a near-term re-rating, she tells investors. She has an EUR9 target on the bank's shares.
08/10/18
MSCO
08/10/18
DOWNGRADE
MSCO
Underweight
Deutsche Bank downgraded to Underweight from Equal Weight at Morgan Stanley
06/01/18
RBCM
06/01/18
DOWNGRADE
RBCM
Underperform
Deutsche Bank downgraded to Underperform from Sector Perform at RBC Capital
PJT PJT Partners
$40.75

-1.05 (-2.51%)

11/19/18
11/19/18
UPGRADE
Target $55

Buy
PJT Partners upgraded to Buy on valuation at BofA/Merrill
As previously reported, BofA/Merrill upgraded PJT Partners to Buy from Neutral and increased its price target to $55 from $53. Analyst Michael Needham said earnings growth is on tract given industry headcount growth can coutnercyclical businesses and valuation has compressed over the last two months.
11/19/18
BOFA
11/19/18
UPGRADE
BOFA
Buy
PJT Partners upgraded to Buy from Neutral at BofA/Merrill
11/06/18
GSCO
11/06/18
INITIATION
Target $60
GSCO
Buy
PJT Partners initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Richard Ramsden started PJT Partners with a Buy rating and $60 price target. The analyst launched coverage of the Independent Advisors with a Neutral rating but sees PTJ as offing best-in-class earnings and revenue growth potential.
07/16/18
07/16/18
DOWNGRADE
Target $60

Neutral
PJT Partners downgraded to Neutral on valuation at BofA/Merrill
As previously reported, BofA/Merrill downgraded PJT Partners to Neutral from Buy and maintained a $60 price target. . Analyst Michael Needham said shares are trading above his existing 2020 base growth outlook and said expectations are high.
MGM MGM Resorts
$27.71

0.33 (1.21%)

01/08/19
JPMS
01/08/19
NO CHANGE
Target $38
JPMS
Overweight
MGM Resorts added to Analyst Focus List at JPMorgan
JPMorgan analyst Joseph Greff added MGM Resorts to his firm's Analyst Focus List saying he sees an increasingly favorable setup for 2019. The analyst raised his price target for the shares to $38 from $35 and keeps an Overweight rating on the name. He sees a combination of relatively low expectations in Las Vegas, improving operations/efficiencies and an attractive valuation.
01/18/19
MSCO
01/18/19
NO CHANGE
MSCO
Overweight
Morgan Stanley prefers Las Vegas to Macau in gaming entering 2019
Morgan Stanley analyst Thomas Allen said he is confident that the Las Vegas outlook is better than perceived after Q4 appears to have shown a meaningful rebound, noting also that his convention tracker supports strong 2019 demand growth and that flight capacity to the market is growing. Meanwhile, as a firm, Morgan Stanley has cut its Macau market gaming revenue outlook and industry view, Allen noted. Combining his Las Vegas outlook and bullish stance on regional U.S. gaming, Allen called MGM Resorts (MGM) and Caesars (CZR) his preferred large cap gaming stocks entering 2019, stating that he believes expectations for both are beatable. He reiterates Overweight ratings on both, as well as on Las Vegas Sands (LVS), and keeps an Equal Weight rating on Wynn Resorts (WYNN).
03/06/19
MSCO
03/06/19
NO CHANGE
MSCO
Morgan Stanley raises Macau casino operator targets on higher mass forecast
Morgan Stanley analyst Thomas Allen said that Morgan Stanley is increasingly bullish that China's policy stimulus is working as a firm, adding that he now expects Macau gross gaming revenue to grow 1% in 2019, up from his prior forecast for a 2% decline. Underpinning that improved view, he has raised his mass market growth forecast to 7% from 2%, citing accelerated visitation growth following the HKZM bridge opening as well as the firm's currency strategists' call for the CNY to continue to appreciate against the USD. While he still has an "in-line" view on Macau, Allen raised his price target on Las Vegas Sands (LVS) to $66 from $64, his target on Wynn (WYNN) to $130 from $122 and his target on MGM Resorts (MGM) to $35 from $34. Allen added that Las Vegas Sands remains his preferred play on Macau, as he thinks the Street is wrong in assuming it will lose market share.
03/20/19
FBCO
03/20/19
INITIATION
Target $30
FBCO
Neutral
MGM Resorts assumed with a Neutral at Credit Suisse
Credit Suisse analyst Ben Combes assumed coverage of MGM Resorts with a Neutral rating and $30 price target.
WYNN Wynn Resorts
$144.62

-0.1 (-0.07%)

04/08/19
04/08/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wynn Resorts (WYNN) upgraded to Buy from Hold at Jefferies with analyst David Katz citing better than expected gross gaming revenue results from Macau for March and signs that suggest to him that it is reasonable to expect economic improvement throughout 2019 in China. 2. e.l.f. Beauty (ELF) upgraded to Neutral from Underweight at JPMorgan. 3. Procter & Gamble (PG) upgraded to Outperform from Market Perform at Wells Fargo with analyst Bonnie Herzog telling investors that while she is "late to the game," she still sees upside and believes P&G has changed and management, led by CEO David Taylor, has infused a sense of urgency and accountability into the organization. 4. AMC Entertainment (AMC) upgraded to Buy from Neutral at B. Riley FBR with analyst Eric Wold saying he has an "increasingly optimistic" view of the EBITDA contribution from Stubs A-List. 5. Zillow (Z, ZG) upgraded to Outperform from Market Perform at Cowen with analyst Thomas Champion saying he believes the new duo of CEO Rich Barton and CFO Allen Parker look well suited for the "massive challenge" of leading the company through a change in business model. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/09/19
DBAB
04/09/19
NO CHANGE
Target $155
DBAB
Buy
Wynn Resorts price target raised to $155 from $145 at Deutsche Bank
Deutsche Bank analyst Carlo Santarelli raised his price target for Wynn Resorts to $155 from $145 and keeps a Buy rating on the shares despite lowering his estimates. The analyst reduced his Las Vegas estimates saying high end is likely to challenge Q1 margins. While Macau fundamentals and any color around the outlook for Macau are likely to play a bigger role around Q1 earnings, Wynn Las Vegas is likely come in below consensus forecasts, Santarelli tells investors in a research note.
04/09/19
MSCO
04/09/19
NO CHANGE
MSCO
Wynn's potential deal for Crown could make strategic sense, says Morgan Stanley
After Crown Resorts announced Wynn Resorts has made an A$14.75 per share takeover proposal, Morgan Stanley analyst Thomas Allen said he thinks a potential deal could make sense as Crown's portfolio would fit into Wynn strategy of owning a handful of luxury assets in the best gaming markets in the world. Assuming Wynn can eliminate 75% of Crown's corporate expense and 2.5% revenue synergies, Allen estimates a deal could be 14% accretive on an EV/EBITDA basis for Wynn.
04/10/19
GSCO
04/10/19
INITIATION
GSCO
Neutral
Wynn Resorts resumed with a Neutral at Goldman Sachs

TODAY'S FREE FLY STORIES

UBER

Uber

$41.40

0.94 (2.32%)

17:49
05/24/19
05/24
17:49
05/24/19
17:49
Hot Stocks
Uber board director Ryan Graves intends to resign »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

APTO

Aptose Biosciences

$2.01

0.03 (1.52%)

17:46
05/24/19
05/24
17:46
05/24/19
17:46
Syndicate
Aptose Biosciences files for $40M at-the-market common stock offering »

Piper Jaffray and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TRNX

Taronis Technologies

$0.48

0.004 (0.84%)

17:26
05/24/19
05/24
17:26
05/24/19
17:26
Syndicate
Breaking Syndicate news story on Taronis Technologies »

Taronis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:25
05/24/19
05/24
17:25
05/24/19
17:25
Hot Stocks
U.S. Energy discloses Nasdaq notice regarding delayed 10-Q filing »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

17:22
05/24/19
05/24
17:22
05/24/19
17:22
Periodicals
Apple sued over allegedly selling users' iTunes data, Bloomberg says »

Apple is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SPCB

SuperCom

$1.17

-0.005 (-0.43%)

17:21
05/24/19
05/24
17:21
05/24/19
17:21
Hot Stocks
SuperCom discloses Nasdaq notice regarding delayed 20-F filing »

SuperCom received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:20
05/24/19
05/24
17:20
05/24/19
17:20
Hot Stocks
U.S. Energy receives noncompliance notice from Nasdaq »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:18
05/24/19
05/24
17:18
05/24/19
17:18
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:17
05/24/19
05/24
17:17
05/24/19
17:17
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$87.49

3.03 (3.59%)

, QGEN

Qiagen

$38.22

-0.255 (-0.66%)

16:57
05/24/19
05/24
16:57
05/24/19
16:57
Hot Stocks
Qiagen launches diagnostic for PIK3CA biomarkers in breast cancer »

Qiagen (QGEN) announced…

NVS

Novartis

$87.49

3.03 (3.59%)

QGEN

Qiagen

$38.22

-0.255 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AVH

Avianca

$3.96

0.91 (29.84%)

16:56
05/24/19
05/24
16:56
05/24/19
16:56
Periodicals
ANAC suspends flights, operations of Avianca Brasil, Reuters reports »

Brazil's ANAC said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

16:53
05/24/19
05/24
16:53
05/24/19
16:53
Periodicals
Apple acquires startup Tueo Health, CNBC reports »

Apple has bought Tueo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SHSP

SharpSpring

$16.37

-0.24 (-1.44%)

16:52
05/24/19
05/24
16:52
05/24/19
16:52
Syndicate
Breaking Syndicate news story on SharpSpring »

SharpSpring files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

CREG

China Recycling Energy

$0.48

0.005 (1.05%)

16:41
05/24/19
05/24
16:41
05/24/19
16:41
Syndicate
Breaking Syndicate news story on China Recycling Energy »

China Recycling Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$3.88

(0.00%)

16:36
05/24/19
05/24
16:36
05/24/19
16:36
Conference/Events
Fennec management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 18

    Jun

TD

Toronto-Dominion

$56.66

0.65 (1.16%)

16:35
05/24/19
05/24
16:35
05/24/19
16:35
Syndicate
Breaking Syndicate news story on Toronto-Dominion »

Toronto-Dominion files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
05/24/19
05/24
16:30
05/24/19
16:30
Options
Preliminary option volume of 15.7M today »

Preliminary option volume…

CBUS

Cibus

$0.00

(0.00%)

16:25
05/24/19
05/24
16:25
05/24/19
16:25
Syndicate
Cibus requests withdrawal of registration statement »

The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$355.14

4.57 (1.30%)

16:23
05/24/19
05/24
16:23
05/24/19
16:23
Periodicals
Boeing 737 MAX return delayed by FAA expanding review, WSJ reports »

A review of Boeing's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

FB

Facebook

$181.03

0.14 (0.08%)

, BA

Boeing

$355.14

4.57 (1.30%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
On The Fly
Fly Intel: Wall Street's top stories for Friday »

U.S. stocks, which had a…

FB

Facebook

$181.03

0.14 (0.08%)

BA

Boeing

$355.14

4.57 (1.30%)

UAL

United Continental

$80.77

-0.14 (-0.17%)

SMI

SMIC

$5.23

-0.26 (-4.74%)

HPQ

HP Inc.

$20.03

0.835 (4.35%)

HPE

HP Enterprise

$14.36

0.03 (0.21%)

NVS

Novartis

$87.49

3.03 (3.59%)

CNC

Centene

$56.84

1.39 (2.51%)

WCG

WellCare

$275.45

0.99 (0.36%)

TSS

TSYS

$113.42

13.81 (13.86%)

GPN

Global Payments

$153.42

5.45 (3.68%)

HIBB

Hibbett Sports

$23.91

4.07 (20.51%)

DVAX

Dynavax

$5.77

-0.59 (-9.28%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

SPLK

Splunk

$119.13

-9.55 (-7.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 13

    Jun

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 09

    Jul

  • 09

    Jul

  • 23

    Jul

  • 13

    Nov

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 24th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
05/24/19
05/24
16:17
05/24/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
05/24/19
05/24
16:16
05/24/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHE

Regional Health Properties

$2.06

0.09 (4.57%)

16:15
05/24/19
05/24
16:15
05/24/19
16:15
Hot Stocks
Regional Health Properties receives NYSE notice over late Form 10-Q filing »

Regional Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBIO

Translate Bio

$9.12

-0.09 (-0.98%)

16:14
05/24/19
05/24
16:14
05/24/19
16:14
Syndicate
Breaking Syndicate news story on Translate Bio »

Translate Bio files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.